Brief: Prime Medicine Announces Pricing Of Upsized Public Offering
15/02/2024 04:50
Feb 14 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE ANNOUNCES PRICING OF UPSIZED PUBLIC
OFFERING
* PRIME MEDICINE INC - UNDERWRITTEN UPSIZED PUBLIC OFFERING
OF
19.2 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING
PRICE OF $6.25 PER SHARE
Source text for Eikon: ID:nGNX5Bd0LT
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease